Lorigerlimab
Product Specifications
CAS Number
2416595-46-3
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation, Cell Cycle/Checkpoint, Apoptosis
Bioactivity
Lorigerlimab (MGD019) is a bispecific IgG4 dual-affinity re-targeting (DART) antibody that inhibits PD-1 and CTLA-4 to enhance T-cell responses, currently being investigated for metastatic castration-resistant prostate cancer (mCRPC) [1] [2] [3].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
OATA00367-100UG 100 µg
OATA00367-100UG - Mouse LPAM-1 Antibody : PE
Sign In for Pricing
View Details 
036857-ML490 100 µL
ICAM2, ID (ICAM2, Intercellular adhesion molecule 2, CD102) (MaxLight 490) discontinued
Sign In for Pricing
View Details 